Safeguarding access to pills from online foreign distributors may become a flashpoint in the reproductive care battle
by Chloe Searchinger
April 5, 2024
After hearing oral arguments last week, the Supreme Court appeared dubious of the plaintiff's legal challenge to the abortion pill in Food and Drug Administration (FDA) v. Hippocratic Alliance of Medicine, the latest major abortion case since Dobbs v. Jackson overturned the constitutional guarantee to an abortion. Even though this outlook could lead pro-choice activists to breathe a minor sigh of relief and temporarily quell Big Pharma's fear over other challenges to FDA approvals, one indirect consequence regardless of the case outcome is the growing American reliance on imported abortion pills from overseas.
This manner of accessing abortion has been increasing in popularity since Dobbs, and safeguarding the provision of these pills from unapproved foreign distributors could soon become a flashpoint in the American battle over reproductive care, given that these imports are illegal because they operate outside the formal U.S. health-care system and beyond FDA oversight.